Home Fresenius Group Business Segments Fresenius Kabi

As one of the leading suppliers of these products, we offer lipid emulsions both as an ingredient of our three-chamber bags and as separate products. In 2007, we introduced our SMOFlipid^® lipid emulsion, used especially for the parenteral nutrition of intensive-care patients, in Austria, Greece, Chile and other countries. 

In the field of enteral nutrition we continued the international marketing of our Fresubin^® product family. In China, in only four years after our first products were launched, we are now one of the leading companies for enteral nutrition. To expand this business further we have introduced the EasyBag for our Fresubin^® tube feed products. The EasyBag is lighter than rigid containers, such as glass bottles, and is safer and easier to use. These advantages have led to a strong market acceptance of this product. Other products from our line of enteral nutrition products launched in Australia and India were also very successful.

Finally, we introduced our Supportan^® sip and tube feed products with a new formulation in 2007. These products are now matched even more specifically to the metabolic needs of oncology patients. The high omega-3 fatty acid eicosapentaen acid (EPA) content can combat the physical emaciation caused by cancer diseases and simultaneously strengthen the body’s immune system. To guarantee the required daily dosage of two grams of EPA, this amount is already contained in one EasyBag of the tube feed Supportan^® or in two Tetra-Pak containers of the sip feed Supportan^®. Our high calorie, high protein and fat rich Supportan^® products enable an optimal supply of energy and nutrients.

Patients with chronic inflammations and those who have undergone surgery have a special need for nutrients to combat oxidative stress and maintain intestinal functions. Glutamine, an amino acid and antioxidants are important active substances used for this purpose. In 2007, we successfully launched our Glutamine Plus product in Austria, Greece and a number of countries in Eastern Europe. Containing glutamine and antioxidants, Glutamine Plus serves to supplement enteral nutrition. It is an oral sip feed supplement in powder form that can be prepared simply by stirring it into water.

Ketosteril^® is a product prescribed for the treatment of chronic kidney disease, primarily in association with predialysis treatment. We are marketing this product very successfully in a number of countries in Latin America, Eastern Europe and the Asia-Pacific region, where we further expanded our market leadership in 2007.

In the field of medical devices for the application of clinical nutrition, we are one of the market leaders in Europe. For the further expansion of our business in the Asia-Pacific region, we have received registrations for our medical devices in Australia, Taiwan, South Korea and China. With Ambix^® activ, we have also developed an infusion pump for parenteral nutrition that is specially designed for outpatient care. The pump’s unique features are its low weight, a battery capacity of up to 40 hours and a rate of delivery adjustable from 10 to 600 ml/h. We plan to bring Ambix^® activ to the market in 2008.